|
1
|
Leroy X, Aubert S, Zini L, Franquet H,
Kervoaze G, Villers A, Delehedde M, Copin MC and Lassalle P:
Vascular endocan (ESM-1) is markedly overexpressed in clear cell
renal cell carcinoma. Histopathology. 56:180–187. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Sarrazin S, Adam E, Lyon M, Depontieu F,
Motte V, Landolfi C, Lortat-Jacob H, Bechard D, Lassalle P and
Delehedde M: Endocan or endothelial cell specific molecule-1
(ESM-1): A potential novel endothelial cell marker and a new target
for cancer therapy. Biochim Biophys Acta. 1765:25–37.
2006.PubMed/NCBI
|
|
3
|
Béchard D, Scherpereel A, Hammad H,
Gentina T, Tsicopoulos A, Aumercier M, Pestel J, Dessaint JP,
Tonnel AB and Lassalle P: Human endothelial-cell specific
molecule-1 binds directly to the integrin CD11a/CD18 (LFA-1) and
blocks binding to intercellular adhesion molecule-1. J Immunol.
167:3099–3106. 2001. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Sarrazin S, Lyon M, Deakin JA, Guerrini M,
Lassalle P, Delehedde M and Lortat-Jacob H: Characterization and
binding activity of the chondroitin/dermatan sulfate chain from
Endocan, a soluble endothelial proteoglycan. Glycobiology.
20:1380–1388. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Scherpereel A, Gentina T, Grigoriu B,
Sénéchal S, Janin A, Tsicopoulos A, Plénat F, Béchard D, Tonnel AB
and Lassalle P: Overexpression of endocan induces tumor formation.
Cancer Res. 63:6084–6089. 2003.PubMed/NCBI
|
|
6
|
Tsai JC, Zhang J, Minami T, Voland C, Zhao
S, Yi X, Lassalle P, Oettgen P and Aird WC: Cloning and
characterization of the human lung endothelial-cell-specific
molecule-1 promoter. J Vasc Res. 39:148–159. 2002. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Depontieu F, Grigoriu BD, Scherpereel A,
Adam E, Delehedde M, Gosset P and Lassalle P: Loss of Endocan
tumorigenic properties after alternative splicing of exon 2. BMC
Cancer. 8:142008. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Scherpereel A, Depontieu F, Grigoriu B,
Cavestri B, Tsicopoulos A, Gentina T, Jourdain M, Pugin J, Tonnel
AB and Lassalle P: Endocan, a new endothelial marker in human
sepsis. Crit Care Med. 34:532–537. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Grigoriu BD, Depontieu F, Scherpereel A,
Gourcerol D, Devos P, Ouatas T, Lafitte JJ, Copin MC, Tonnel AB and
Lassalle P: Endocan expression and relationship with survival in
human non-small cell lung cancer. Clin Cancer Res. 12:4575–4582.
2006. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Aitkenhead M, Wang SJ, Nakatsu MN, Mestas
J, Heard C and Hughes CCW: Identification of endothelial cell genes
expressed in an in vitro model of angiogenesis: Induction of ESM-1,
(beta)ig-h3, and NrCAM. Microvasc Res. 63:159–171. 2002. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Rennel E, Mellberg S, Dimberg A, et al:
Endocan is a VEGF-A and PI3K regulated gene with increased
expression in human renal cancer. Exp Cell Res. 313:1285–1294.
2007. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Béchard D, Gentina T, Delehedde M, et al:
Endocan is a novel chondroitin sulfate/dermatan sulfate
proteoglycan that promotes hepatocyte growth factor/scatter factor
mitogenic activity. J Biol Chem. 276:48341–48349. 2001.PubMed/NCBI
|
|
13
|
Li S, Wang L, Wang C, et al: Detection on
dynamic changes of endothelial cell specific molecule 1 in acute
rejection after renal transplantation. Urology. 80(738): e1–8.
2012.
|
|
14
|
Li S, Liang P, Zhao Y, et al: Detection
and mechanism of action of ESM-1 in rat kidney transplantation
under various immune states. Cell Immunol. 283:31–37. 2013.
View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Bechard D, Meignin V, Scherpereel A, Oudin
S, Kervoaze G, Bertheau P, Janin A, Tonnel A and Lassalle P:
Characterization of the secreted form of endothelial-cell-specific
molecule 1 by specific monoclonal antibodies. J Vasc Res.
37:417–425. 2000. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Gerritsen ME, Tomlinson JE, Zlot C, Ziman
M and Hwang S: Using gene expression profiling to identify the
molecular basis of the synergistic actions of hepatocyte growth
factor and vascular endothelial growth factor in human endothelial
cells. Br J Pharmacol. 140:595–610. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Abid MR, Yi X, Yano K, Shih SC and Aird
WC: Vascular endocan is preferentially expressed in tumor
endothelium. Microvasc Res. 72:136–145. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Maurage CA, Adam E, Minéo JF, Sarrazin S,
Debunne M, Siminski RM, Baroncini M, Lassalle P, Blond S and
Delehedde M: Endocan expression and localization in human
glioblastomas. J Neuropathol Exp Neurol. 68:633–641. 2009.
View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Lassalle P, Molet S, Janin A, Heyden JV,
Tavernier J, Fiers W, Devos R and Tonnel AB: ESM-1 is a novel human
endothelial cell-specific molecule expressed in lung and regulated
by cytokines. J Biol Chem. 271:20458–20464. 1996. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Kang YH, Ji NY, Lee CI, et al: ESM-1
silencing decreased cell survival, migration, and invasion and
modulated cell cycle progression in hepatocellular carcinoma. Amino
Acids. 40:1003–1013. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Chen LY, Liu X, Wang SL and Qin CY:
Over-expression of the Endocan gene in endothelial cells from
hepatocellular carcinoma is associated with angiogenesis and tumour
invasion. J Int Med Res. 38:498–510. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Xiang X, Zhao WB and Wang X: Expression of
ESM-1 in hepatocellular carcinoma is associated with angiogenesis
and tumor invasion. Zhonghua Gan Zang Bing Za Zhi. 17:661–664.
2009.[(In Chinese)]. PubMed/NCBI
|
|
23
|
Ziol M, Sutton A, Calderaro J, et al:
ESM-1 expression in stromal cells is predictive of recurrence after
radiofrequency ablation in early hepatocellular carcinoma. J
Hepatol. 59:1264–1270. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Kim JH, Park MY, Kim CN, Kim KH, Kang HB,
Kim KD and Kim JW: Expression of endothelial cell-specific
molecule-1 regulated by hypoxia inducible factor-1α in human colon
carcinoma: Impact of ESM-1 on prognosis and its correlation with
clinicopathological features. Oncol Rep. 28:1701–1708.
2012.PubMed/NCBI
|
|
25
|
Kang YH, Ji NY, Han SR, et al: ESM-1
regulates cell growth and metastatic process through activation of
NF-κB in colorectal cancer. Cell Signal. 24:1940–1949. 2012.
View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Liu N, Zhang LH, Du H, Hu Y, Zhang GG,
Wang XH, Li JY and Ji JF: Overexpression of endothelial cell
specific molecule-1 (ESM-1) in gastric cancer. Ann Surg Oncol.
17:2628–2639. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Lv Z, Fan Y, Chen H and Zhao D:
Endothelial cell-specific molecule-1: A potential serum marker for
gastric cancer. Tumour Biol. 35:10497–10502. 2014. View Article : Google Scholar : PubMed/NCBI
|
